IL2 and prostate neoplasm: To assess the effect of IL-15 on anti-tumor activity, Vγ2Vδ2 T cells expanded using pulse zoledronate stimulation with either IL-15 or IL-2 were adoptively transferred into NSG mice bearing PC-3 prostate tumors (Fig. 7a).